Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Unger

Showing results (11-20 of 446) with videos related to

Pageof 45
Sort By:
Fortschritte Der Medizin|August 30, 1997
[Differential therapy of hypertension becomes more specific. Interview by Dr. R.-G. Sommer]T Unger
Fortschritte Der Medizin|January 7, 1998
[Antihypertensive therapy: the end of the flag pole?]T Unger
Blood Pressure. Supplement|November 4, 2000
Differences among angiotensin II type 1 receptor blockers: characteristics of candesartan cilexetilT Unger
Blood Pressure. Supplement|October 31, 2001
Pharmacology of AT1-receptor blockersT Unger
Blood Pressure. Supplement|May 3, 2001
Inhibiting renin-angiotensin in the brain: the possible therapeutic implicationsT Unger
Journal of Hypertension|March 7, 2000
The angiotensin type 2 receptor: variations on an enigmatic themeT Unger
The American Journal of Cardiology|December 10, 1999
Significance of angiotensin type 1 receptor blockade: why are angiotensin II receptor blockers different?T Unger
MMW Fortschritte Der Medizin|October 29, 2000
[Physician-patient interaction in hypertension. Partnership with defined roles]T Unger
Journal of Human Hypertension|January 1, 1995
Patient-doctor interactions in hypertensionT Unger
Deutsche Medizinische Wochenschrift (1946)|October 31, 2009
[Antihypertensives as over-the-counter drugs?]T Unger
Pageof 45

Showing results (11-20 of 446) with videos related to

Sort By:
Pageof 45
Fortschritte Der Medizin|August 30, 1997
[Differential therapy of hypertension becomes more specific. Interview by Dr. R.-G. Sommer]T Unger
Fortschritte Der Medizin|January 7, 1998
[Antihypertensive therapy: the end of the flag pole?]T Unger
Blood Pressure. Supplement|November 4, 2000
Differences among angiotensin II type 1 receptor blockers: characteristics of candesartan cilexetilT Unger
Blood Pressure. Supplement|October 31, 2001
Pharmacology of AT1-receptor blockersT Unger
Blood Pressure. Supplement|May 3, 2001
Inhibiting renin-angiotensin in the brain: the possible therapeutic implicationsT Unger
Journal of Hypertension|March 7, 2000
The angiotensin type 2 receptor: variations on an enigmatic themeT Unger
The American Journal of Cardiology|December 10, 1999
Significance of angiotensin type 1 receptor blockade: why are angiotensin II receptor blockers different?T Unger
MMW Fortschritte Der Medizin|October 29, 2000
[Physician-patient interaction in hypertension. Partnership with defined roles]T Unger
Journal of Human Hypertension|January 1, 1995
Patient-doctor interactions in hypertensionT Unger
Deutsche Medizinische Wochenschrift (1946)|October 31, 2009
[Antihypertensives as over-the-counter drugs?]T Unger
Pageof 45